Drug price history · CMS NADAC read 11 November 2026

What have pharmacies paid for Dihydroergotamine Mesylate since 2013?

What pharmacies pay, not what you pay. Dihydroergotamine Mesylate has 1 product in the CMS NADAC survey, 1 product with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Dihydroergotamine Mesylate 4 MG/ML Nasal Spray: $169 per unit at the 2013 survey and $39.25 at 2026 (−77%, thin).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Dihydroergotamine Mesylate1 product in NADAC
1product with a price history
  1. Dihydroergotamine Mesylate has 1 product in the CMS NADAC survey, 1 product with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
  2. 1 of the changes rest on fewer than 3 priced NDCs at one end and are marked thin: a median over one or two NDCs reflects which NDCs were priced as much as a price movement.
  3. This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.

Dihydroergotamine Mesylate 4 MG/ML Nasal Spray

Generic

$169 per mL at the 2013 year-end survey (1 NDC) and $39.25 at the 2026 survey (10 NDCs): −77%, a thin comparison.

$0$3762013: median $169 per mL, 1 NDC priced2014: median $274 per mL, 1 NDC priced2015: median $352 per mL, 1 NDC priced2016: median $349 per mL, 1 NDC priced2017: median $376 per mL, 1 NDC priced2018: median $322 per mL, 1 NDC priced2019: median $348 per mL, 1 NDC priced2020: median $263 per mL, 3 NDCs priced2021: median $144 per mL, 4 NDCs priced2022: median $147 per mL, 4 NDCs priced2023: median $34.21 per mL, 6 NDCs priced2024: median $35.13 per mL, 5 NDCs priced2025: median $32.35 per mL, 5 NDCs priced2026: median $39.25 per mL, 10 NDCs priced20132015201720192021202320252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per mLLowest to highestNDCs priced
2013 (2013-12-25)$1691
2014 (2014-12-31)$2741
2015 (2015-12-30)$3521
2016 (2016-12-28)$3491
2017 (2017-12-27)$3761
2018 (2018-12-26)$3221
2019 (2019-12-25)$3481
2020 (2020-12-30)$2633
2021 (2021-12-29)$1444
2022 (2022-12-28)$1474
2023 (2023-12-27)$34.216
2024 (2024-12-25)$35.135
2025 (2025-12-31)$32.355
2026 (2026-11-11)$39.25$29.35 to $49.1410

CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.

How many companies make Dihydroergotamine Mesylate?

The FDA Orange Book lists 4 generic makers as marketed in its largest dosage form for Dihydroergotamine Mesylate, and the first generic approval is dated 28 April 2003. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.

Where can you go from this record?

Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Dihydroergotamine Mesylate on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).